207 related articles for article (PubMed ID: 29192390)
1. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid.
van Bussel MTJ; Pluim D; Bol M; Beijnen JH; Schellens JHM; Brandsma D
J Neurooncol; 2018 Mar; 137(1):1-10. PubMed ID: 29192390
[TBL] [Abstract][Full Text] [Related]
2. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
[TBL] [Abstract][Full Text] [Related]
4. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
5. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
[TBL] [Abstract][Full Text] [Related]
6. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis.
Torre M; Lee EQ; Chukwueke UN; Nayak L; Cibas ES; Lowe AC
J Am Soc Cytopathol; 2020; 9(1):45-54. PubMed ID: 31606331
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
[TBL] [Abstract][Full Text] [Related]
8. Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
Subirá D; Serrano C; Castañón S; Gonzalo R; Illán J; Pardo J; Martínez-García M; Millastre E; Aparisi F; Navarro M; Dómine M; Gil-Bazo I; Pérez Segura P; Gil M; Bruna J
Neuro Oncol; 2012 Jan; 14(1):43-52. PubMed ID: 21993441
[TBL] [Abstract][Full Text] [Related]
9. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
10. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
[TBL] [Abstract][Full Text] [Related]
11. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
Darlix A; Cayrefourcq L; Pouderoux S; Menjot de Champfleur N; Bievelez A; Jacot W; Leaha C; Thezenas S; Alix-Panabières C
Clin Chem; 2022 Oct; 68(10):1311-1322. PubMed ID: 35953885
[TBL] [Abstract][Full Text] [Related]
12. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
[TBL] [Abstract][Full Text] [Related]
13. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
Hristozova T; Konschak R; Budach V; Tinhofer I
Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.
Cordone I; Masi S; Summa V; Carosi M; Vidiri A; Fabi A; Pasquale A; Conti L; Rosito I; Carapella CM; Villani V; Pace A
Breast Cancer Res; 2017 Apr; 19(1):46. PubMed ID: 28399903
[TBL] [Abstract][Full Text] [Related]
16. A Novel Workflow to Enrich and Isolate Patient-Matched EpCAM
Lampignano R; Yang L; Neumann MHD; Franken A; Fehm T; Niederacher D; Neubauer H
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858218
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
[TBL] [Abstract][Full Text] [Related]
18. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
19. CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis.
Tu Q; Wu X; Le Rhun E; Blonski M; Wittwer B; Taillandier L; De Carvalho Bittencourt M; Faure GC
Lung Cancer; 2015 Nov; 90(2):352-7. PubMed ID: 26386833
[TBL] [Abstract][Full Text] [Related]
20. Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells.
Jiang BY; Li YS; Guo WB; Zhang XC; Chen ZH; Su J; Zhong WZ; Yang XN; Yang JJ; Shao Y; Huang B; Liu YH; Zhou Q; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Wu SY; Gao CY; Zhang X; Wu YL
Clin Cancer Res; 2017 Sep; 23(18):5480-5488. PubMed ID: 28606923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
